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The cytoplasm of eukaryotic cells is thought to adopt discrete ‘‘states’’ corresponding to different steady states of
protein networks that govern changes in subcellular organization. For example, in Xenopus eggs, the interphase to
mitosis transition is induced solely by activation of cyclin-dependent kinase 1 (CDK1) that phosphorylates many
proteins leading to a reorganization of the nucleus and assembly of the mitotic spindle. Among these changes, the
large array of stable microtubules that exists in interphase is replaced by short, highly dynamic microtubules in
metaphase. Using a new visual immunoprecipitation assay that quantifies pairwise protein interactions in a non-
perturbing manner in Xenopus egg extracts, we reveal the existence of a network of interactions between a series of
microtubule-associated proteins (MAPs). In interphase, tubulin interacts with XMAP215, which is itself interacting with
XKCM1, which connects to APC, EB1, and CLIP170. In mitosis, tubulin interacts with XMAP215, which is connected to
EB1. We show that in interphase, microtubules are stable because the catastrophe-promoting activity of XKCM1 is
inhibited by its interactions with the other MAPs. In mitosis, microtubules are short and dynamic because XKCM1 is
free and has a strong destabilizing activity. In this case, the interaction of XMAP215 with EB1 is required to counteract
the strong activity of XKCM1. This provides the beginning of a biochemical description of the notion of ‘‘cytoplasmic
states’’ regarding the microtubule system.
Citation: Niethammer P, Kronja I, Kandels-Lewis S, Rybina S, Bastiaens P, et al. (2007) Discrete states of a protein interaction network govern interphase and mitotic
microtubule dynamics. PLoS Biol 5(2): e29. doi:10.1371/journal.pbio.0050029
Introduction
Understanding the functional consequences of interactions
between multiple components of a complex biological system
is a challenge. Typical proteomic approaches provide only
snapshots of one speciﬁc state of a network of interactions.
Usually, they do not contain information about how
biochemical changes cause functional changes, nor do they
reveal the extent to which protein interactions occur in the
cell [1]. By contrast, typical cell biological studies concentrate
on the function of only one component or interaction at a
time, mostly by using RNA interference (RNAi), genetics, co-
localization, or immunodepletion experiments. Those ap-
proaches tend to overemphasize the importance of binary
interactions while missing the signiﬁcance of network
behavior.
Several MAPs involved in the regulation of microtubule
(MT) dynamics in vivo have been characterized recently
(XMAP215, XKCM1, EB1, APC, and CLIP170) [2]. XMAP215
and EB1 are known MT stabilizers, whereas XKCM1 is a
destabilizer [3–5]. The function of APC remains unclear
although several reports indicate that it possibly interacts
with EB1 in order to stabilize MTs [6,7]. CLIP170 seems to
participate in the local regulation of MT dynamics [8–10].
Although there is a wealth of data on these MAPs, no
coherent picture concerning their potential collective effects
on MT growth in one single system has emerged yet. Thus, we
decided to examine the mutual interactions of the above-
mentioned molecules and their effects on MT dynamics in
Xenopus egg extracts. This undiluted frog egg cytoplasm
recapitulates the cell cycle, mimics in vivo conditions, and
allows biochemical analysis of MT dynamics in two well-
deﬁned states, interphase and mitosis [11–13]. Using a newly
developed interaction assay (visual immunoprecipitation
[VIP]) we have imaged directly in such extracts the
interaction patterns of MAPs in interphase and mitosis. We
have correlated this study with an analysis of MT growth in
response to immunodepletion of individual MAPs as a
function of cell-cycle state. The combined data of these two
approaches strongly suggest that in interphase, the extensive
growth and stability of MTs are caused by an inhibition of the
destabilizing factor XKCM1 through multiple interactions
with other MAPs (XMAP215, CLIP170, EB1, and APC). By
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PLoS BIOLOGYcontrast, in mitosis, MTs become highly dynamic because
these interactions are disrupted, activating the catastrophe-
promoting activity of XKCM1. Under such conditions, a
complex of XMAP215 and EB1 is required for MT growth.
Results
The Visual Immunoprecipitation Assay
Standard immunoprecipitation (IP) techniques are time
consuming and insensitive to low-afﬁnity interactions, and
their results vary considerably with different washing
conditions. Moreover, interactions that are maintained by
enzymatic activities in the cytoplasm are likely to be lost
during the IP procedure. Such approaches are, therefore, not
well adapted to the analysis of protein interaction networks
that are likely to consist of functionally important low-afﬁnity
or labile interactions. Most of the in situ microscopy
techniques currently available (ﬂuorescence resonance en-
ergy transfer [FRET] and ﬂuorescence cross-correlation
spectroscopy [FCCS]) require advanced instrumentation,
elaborate image analysis, and ﬂuorescent labeling of all
interaction partners that are to be studied. In addition, they
are not well suited for the simultaneous detection of multiple
interactions in the same sample. Thus, we set out to develop
VIP as a novel microscopy technique allowing direct imaging
of multiple protein interactions in Xenopus egg extracts.
Antibody-coated, micrometer-sized beads are introduced
into extracts that contain ﬂuorescently labeled recombinant
proteins. Interaction between an endogenous protein trap-
ped on the bead (bait) and a labeled protein (prey) in the
extract is detected by the ﬂuorescence signal of the prey
bound to the beads (Figure 1A). By encrypting the different
bait-bead loads with distinguishable ﬂuorescence intensities
at a given spectral window, multiple protein interactions can
be detected simultaneously within the same sample (Figure
1A). The speciﬁc signals are corrected for varying contribu-
tions of autoﬂuorescence or unspeciﬁc binding, measured on
Alexa405-labeled IgG-coated control beads included within
the same sample (Figure 1B). Images are acquired with a
confocal microscope. Confocal imaging allows optimization
of the ratio between background and bead ﬂuorescence by
adjusting the pinhole/slice thickness. Sequential line scanning
of all channels ensures minimal bleed through or cross-
excitation. Acquisitions include a transmission and Alexa405
image, together with a variable number of images from
‘‘signal’’ channels (prey emission, e.g., enhanced green
ﬂuorescent protein [EGFP]; Figure 1A and 1B). The trans-
mission image allows the identiﬁcation of single beads by
edge detection (Figure 1B). Then, coordinates (x,y) are
assigned to that bead by segmentation (Figure 1B). Detection
of beads from the transmission image has the advantage that
object recognition is not biased by a (potentially heteroge-
neous) ﬂuorescence signal coming from the bead. Unfocused
beads are excluded from the bead mask on reﬂection criteria.
Control and bait beads are subsequently distinguished as
different intensity populations (Figure 1C; Alexa405, 405-nm
histogram) in the Alexa405 channel (bait-coding channel).
This allows the generation of two bead masks, one comprising
only bait beads, the other comprising only control beads. The
binding of the ﬂuorescent prey to the bait beads (bait-bead
intensity) and to control beads (control-bead intensities) is
then measured by applying the masks on the ‘‘prey’’ channels,
e.g., EGFP channel (Figure1C; EGFP, 488-nm histogram).
Speciﬁc bait-bead intensities are calculated by subtracting
the median control-bead intensity from the ﬂuorescence
intensity on each bait bead in the same image. The speciﬁc
bait intensity in each image is calculated as the median of the
speciﬁc bait-bead intensities (,Ivip.) only if the intensity
difference of bait and control beads in an image is found to
be signiﬁcant (p , 0.05) by an unpaired Student t-test.
Otherwise (p . 0.05), the signal is set to zero (Figure 1B). The
Student t-test ﬁlter ensures that signals on the bait beads are
only scored as interactions if there is a signiﬁcant intensity
difference with the control beads in the same image.
Background subtraction allows a direct comparison of
interaction signals between samples from different extracts.
The image processing has been automated using MATLAB
routines (http://www.mathworks.com/).
To validate the VIP assay, we measured the dissociation
constant (Kd) of an antibody-antigen interaction and
conﬁrmed the already reported binding of EB1 to the MT-
binding domain of APC (APCMTBD; Figure S1A) [14]. As
anticipated, VIP revealed a nanomolar Kd for the antibody-
antigen interaction (Figure 2A) and gave a strong signal for
the APCMTBD-EB1 interaction speciﬁcally in interphase
(Figure 2B), but not in metaphase in which the signal was
below the signiﬁcance criteria. We also examined the
interaction in buffer (CSF-XB) of puriﬁed XMAP215 with
EB1-EGFP using VIP and of XMAP215-EGFP with EB1-Cy3
using FRET. The two methods gave similar Kds (Figure 2C).
Although we could detect the interaction of the endogenous
XMAP215 and EB1 in metaphase extracts only by VIP (Figure
2D, right panel) and not by regular IP (Figure 2D, left panel),
the binding of XMAP215 to the C-terminal domain of EB1 (C-
EB1; Figure 2E) was revealed by both techniques.
MAP Interaction Networks in Interphase and Mitosis
Using VIP, we set out to visualize the interaction pattern
between ﬁve important regulators of MT dynamics
Author Summary
When eukaryotic cells undergo cell division, a dramatic reorganiza-
tion occurs during the transition from interphase to metaphase. The
cell rounds up, chromosomes condense, the nuclear envelope
breaks down, and microtubules (proteins that help maintain the
cell’s shape) become very short and dynamic before assembly of the
mitotic spindle (the structure that pulls chromosomes apart).
Although it is known that the CDK1 kinase induces this reorganiza-
tion, the precise mechanisms that regulate such coordinated
changes are not yet understood. To investigate the regulation of
microtubule dynamics, we applied a new method, called visual
immunoprecipitation (VIP), that enables simultaneous visualization
of multiple protein interactions in cell extracts. There are two known
major regulators of microtubule dynamics: a stabilizer (XMAP215)
and a destabilizer (XKCM1); a series of other molecules (EB1, APC,
and CLIP 170) are also involved, although their roles in the global
regulation of microtubule dynamic instability are not as clear. We
show here that microtubules are stable during interphase because
the destabilizer is inhibited by the other molecules. During mitosis,
however, the destabilizer is released, triggering the alteration of
microtubule structure and dynamics. Thus, microtubule dynamics
change in response to a dramatic switch in the interactions of a set
of proteins.
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Protein Network and Microtubule Dynamics(XMAP215, XKCM1, CLIP170, APC, and EB1) in interphase
and metaphase Xenopus egg extracts. We observed a switch in
global MAP interactions between interphase and metaphase
(Figure 3A). First, we found a clear interaction between the
MT destabilizer XKCM1 and all other MAPs in interphase
that disappeared or was strongly decreased in metaphase.
Second, the MT stabilizer XMAP215 that did not interact with
EB1 in interphase was found to do so in metaphase. Third,
CLIP170 that did not interact with EB1 in interphase did so
weakly in metaphase. XMAP215-EB1 and XMAP215-XKCM1
binding persisted upon switching of bait and prey (unpub-
lished data). Interestingly, XMAP215, but not EB1, showed a
strong interaction with tubulin both in interphase and
metaphase. This is in line with a recent study that reported
an interaction of the yeast homolog of XMAP215 (Stu2p) with
tubulin [15]. With an anti-APCMTBD antibody, we could not
detect a cytosolic interaction between full-length APC and
full-length EB1-EGFP either in interphase or metaphase
(Figure 3A). With the same bait-prey combination, we found
that the 16 nM of added recombinant APCMTBD did interact
with EB1-EGFP speciﬁcally in interphase (unpublished data)
as previously reported in the literature [7]. Additionally, we
found that endogenous EB1 recruited to an anti-EB1
antibody interacted with Cy5-labeled APCMTBD also only
in interphase (Figure 3A). Thus, antibody interference with
bait-prey binding cannot explain the lack of interaction
between full-length APC and EB1. This also indicates that the
APC fragment missing in the APCMTBD contributes to the
regulation of interaction between full-length APC and EB1
under physiological conditions. By contrast, antibody inter-
ference seemed to be an issue for the XKCM1-EB1 inter-
action. Here, we could only reveal the interaction by using
endogenous EB1 as bait and XKCM1-EGFP (Figure S1B) as
prey. Because full or partial overlap of bait-binding epitopes
for antibody and prey is anticipated to interfere with bait-
prey interaction, for VIP, as well as for other antibody-based
methods, conﬁdence about negative signals absolutely re-
quires positive controls. In the present case, the strong
differences in MAP interactions observed in interphase and
metaphase extracts provide positive and negative internal
controls. Interestingly, the C-EB1 fragment interacted with
XMAP215 in metaphase and to a lesser extent in interphase,
suggesting that the regulated interaction observed between
the wild-type proteins was partly removed from the frag-
ments. XKCM1 that interacted strongly with C-EB1 and the
APCMTBD in interphase still did so in metaphase, showing
that cell-cycle regulation observed for wild-type proteins was
also lost in these fragments. A similar observation was made
for the interaction of EB1 with a fragment of CLIP170 (Figure
3A; the CLIP-170 H2 domain [CLIPH2], Figure S1A).
To determine whether the observed switch in MAP
interaction was triggered by cyclin-dependent kinase 1
(CDK1), we followed the interaction between XMAP215,
EB1, and the APCMTBD when the extracts were induced to
shift from metaphase to interphase by adding calcium and
back to metaphase by adding puriﬁed active CDK1/cyclinB
complex [16]. As shown in Figure 3B, the interaction between
XMAP215 and EB1 as well as between APCMTBD and EB1
changed accordingly, demonstrating that these interactions
are indeed modulated by CDK1 activity. Importantly,
XMAP215-EB1, XMAP215-XKCM1, and APCMTBD-EB1
binding were abolished by addition of okadaic acid (OA) to
the extracts (Figure 3C), indicating that their steady-state
interaction levels are also maintained by phosphatase
activities present in the extract.
Causal Relationships between the MAP Network and MT
Dynamic States
The two discrete MAP interaction states correlate with two
discrete phenotypes of the MT system (Figure 3A, lower
panel). In interphase extracts, MTs are long and stable
because there are almost no catastrophes and they grow
continuously as long as there is enough soluble tubulin and
MAPs. In mitosis, catastrophes are relatively frequent,
resulting in highly dynamic MTs that reach a steady-state
length after a few minutes of growth [17]. In an attempt to
establish a causal relationship between the observed MAP
network states and these MT phenotypes, we performed a
variety of perturbation assays and analyzed their effects on
the length of MTs nucleated from centrosomes added to egg
extracts. Depletion of XMAP215 completely blocked MT
growth both in interphase and metaphase extracts as
previously reported (Figure 4A, Figure S2A) [3]. Adding back
XMAP215 restored MT growth. EB1 depletion dramatically
reduced MT growth in metaphase, but caused only a minor
reduction in aster size in interphase (Figure 4B, Figure S2B)
[4]. When MT dynamics were measured in interphase, the
effect of EB1 depletion was a 2-fold decrease in polymer-
ization rate, associated with a 2-fold increase in pausing time
(Figure 4C). These dynamic measurements are consistent with
the small effect of EB1 depletion on MT length in interphase
(Figure 4B). Adding back recombinant EB1 to EB1-depleted
metaphase extracts restored MT growth (Figure 4B, Figure
S2B). Interestingly, the inhibition of MT growth caused by
EB1 depletion from metaphase extracts could also be rescued
by adding back an excess of XMAP215 (Figure 4B). On the
other hand, adding back only EB1 to XMAP215-depleted
extracts did not restore MT growth either in interphase or in
metaphase (Figure 4A). This indicates that EB1 is not
required for MT stabilization in interphase, and that in
metaphase, it cannot stabilize MTs in the absence of
XMAP215. Moreover, this shows that in metaphase, physio-
logical XMAP215 concentrations cannot support MT growth
in the absence of EB1. EB1 depletion did not cause any
decrease in the amount of XMAP215 left in the supernatant,
and we never found EB1 in XMAP215 IPs or vice versa. This
excludes the possibility that the destabilization of MTs
observed in EB1-depleted extracts is caused by a co-depletion
of XMAP215. Aster size was not affected by APC depletion
either in interphase or metaphase extracts (Figure S2B),
arguing against the idea that APC stabilizes MTs [18,19] in
Xenopus egg extracts.
Together with the VIP results, these data strongly suggested
a physiological importance for the XMAP215-EB1 interaction
in metaphase providing a ﬁrst indication of a causal
relationship between the two MAP network states and the
respective MT phenotypes. An interaction between the
Dictyostelium XMAP215 (DdCP224) and EB1 homologs has
been reported using IP [20] and tandem afﬁnity puriﬁcation
[21]. We also observed a direct interaction between puriﬁed
XMAP215 and EB1 by in vitro VIP and FRET assays (Figure
2C). This shows that both proteins do interact directly, but
that this interaction is inhibited in interphase egg extracts
(Figure 3A). From the VIP and FRET data and the measured
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Protein Network and Microtubule Dynamicsendogenous concentrations of the two proteins (270 nM for
EB1 and 600 nM for XMAP215 [4,22] and our unpublished
data), we could estimate that at least one third of the EB1
should interact with XMAP215 in metaphase egg extracts. We
generated EB1 fragments (Figure S1A) in an attempt to
directly interfere with this interaction in the extracts. The C-
terminal part of EB1 (C-EB1) turned out to efﬁciently bind to
XMAP215 (Figure 2E), thereby obstructing its interaction
with full-length EB1 (Figure 5A, inset). This fragment also
completely inhibited MT growth in metaphase just as EB1
depletion did (Figure 5A). By contrast, in interphase extracts,
C-EB1 did not induce the formation of short asters (Figure
5B), corroborating the mitotic-speciﬁc function of XMAP215-
EB1 interaction. Removal of p150
glued from metaphase
extracts did not have an effect on aster size (Figure S2C),
and C-EB1 interacted very weakly with EB1 (Figure 2E, right
panel), excluding the possibility that the C-EB1 phenotype
was created by interference with p150
glued-EB1 interaction
[23,24] or artiﬁcial auto-inhibition of EB1 by C-EB1 [25].
Although we cannot exclude that C-EB1 destabilizes MTs by
some unknown mechanism, the data strongly suggest that the
speciﬁc interaction observed in metaphase between
XMAP215 and EB1 is required for proper MT dynamics in
this cytoplasmic state.
In interphase, the situation is different: XMAP215 does not
interact with EB1, but MTs are long and extremely stable. In
this case, the main MT destabilizer, XKCM1, interacts with
XMAP215, EB1, CLIP170, and APC. We therefore examined
whether the catastrophe-promoting activity of XKCM1 could
be inhibited by these interactions. Indeed in interphase
extracts, there are so few catastrophes that even when
XKCM1 is depleted, there is no signiﬁcant increase in the
size of asters (Figure S2A). The analysis of MT dynamics in
interphase extracts depleted from XKCM1 showed marginally
signiﬁcant effects on the catastrophe frequency, growth, and
shrinking rates as well as a seemingly large effect on rescue
frequency (Figure 6A). The poor effect on catastrophe
frequency was expected due to the already very low
catastrophe frequency in interphase cytoplasm [12,17], and
the apparent increase in rescues is not statistically signiﬁcant
because only three shrinking MTs were observed over a very
short shrinking period (fres ¼ rescue events per depolymeri-
zation time). This indicated that XKCM1 is inactive in
interphase. In order to test this, we added increasing amounts
of XKCM1 to interphase and metaphase extracts. In
metaphase, the addition of 150 nM XKCM1 above the
endogenous concentration (120 nM [5]) completely blocked
MT growth, whereas in interphase, the addition of a large
excess of XKCM1 (600 nM) did not eliminate MT growth
(Figure 6B).
If XKCM1 were inactivated through its interaction with
MAPs in the interphase extract, adding it to extracts depleted
of individual interaction partners should have a strong effect
on MT destabilization. As shown in Figure 6C and 6D, this was
indeed the case. We ﬁrst added increasing amounts of
XKCM1 to an extract depleted of XMAP215 and supple-
mented with a small amount of XMAP215 (40 nM) in order to
be able to observe MTs of a signiﬁcant length (;13.3 lm).
Adding only 75 nM XKCM1 to these extracts dramatically
reduced the size of MTs, whereas in the control extract,
signiﬁcant destabilization occurred only around 600 nM
(Figure 6C and 6D). Then, we added increasing amounts of
XKCM1 to extracts from which we had removed APC or EB1
or both APC and EB1. When APC or EB1 were individually
depleted from the interphase extract, XKCM1 strongly
destabilized MTs at 75 nM (Figure 6C and 6D). Interestingly,
although depleting EB1 or APC alone had no effect on MT
length, the double depletion had a dramatic effect, leading to
a reduction in MT size from about 20 lmt o7lm (Figure 6C
and 6D). In this case, adding excess XKCM1 lead only to a
marginal additional shortening of MTs. As seen in Figure 6C
and 6D, adding a large excess of XKCM1 does not fully inhibit
MT growth (we observed a minimum length of about 5 lm) in
the interphase extract depleted of APC, EB1, or both APC
and EB1. The only way to eliminate MT growth was to deplete
XMAP215 or to add excess XKCM1 in the extract that was
partially depleted of XMAP215 (Figure 4A, Figure 6C and 6D,
and Figure S2A).
This indicates that APC and EB1 have a synergistic effect
on MT growth in interphase by inactivating XKCM1. To
further establish this ‘‘buffering’’ effect of APC and EB1 on
XKCM1 activity, we carried out a triple depletion of APC,
EB1, and XKCM1 from the interphase extract. If the lack of
APC and EB1 caused a shortening of MTs by unleashing
XKCM1, removal of endogenous XKCM1 should rescue aster
size to wild-type length. This is indeed the case as shown in
Figure S2D. These functional data together with our VIP
results strongly suggest that in interphase, MTs are stable,
because the catastrophe-promoting activity of XKCM1 is
inhibited through multiple interactions with XMAP215, APC,
and EB1.
Discussion
We hypothesized that a MAP interaction network may
change state when cells alternate between interphase and
mitosis, resulting in different MT dynamics. To test this
hypothesis, we developed VIP and used it in Xenopus egg
extracts in which the cytoplasm is unperturbed [26]. Such
extracts also support the assembly of nuclei as well as spindles
around added DNA in a cell cycle–dependent manner [27].
Figure 1. The VIP Assay
(A) Scheme of VIP methodology. AB1/AB2: specific antibodies recognizing endogenous bait.
(B) Flow diagram of the automated image processing used for VIP.
(C) Histograms of Alexa405 fluorescence (left panel) and EGFP fluorescence (right panel) on beads in an in vitro VIP experiment in which 1,600 nM EB1-
EGFP was titrated into CSFXB buffer containing 300 nM XMAP215, anti-XMAP215 beads, and Alexa405-IgG beads. Different bead species (IgG/bait
beads) are encoded by distinct Alexa405 emission (left panel). Each bead species is defined by the S.D. of Gaussian distributions (the black arrow marks
the beginning and the grey arrow the end of the confidence interval) fitted to the Alexa405 histogram. Beads with Alexa405 intensities lying within the
S.D. of the low-intensity population are defined as IgG beads. Beads with Alexa405 intensities lying within the S.D. of the high-intensity population are
defined as bait beads (here: anti-XMAP215 beads). The emission of the two species (black: IgG beads; and red: anti-XMAP215 beads) in the EGFP
channel is represented as a histogram (right panel). The VIP signal is calculated by subtracting the median intensity of bait beads in the EGFP channel by
the median intensity of IgG beads in the EGFP channel only if there is a significant difference (p , 0.05, unpaired t-test) between these two populations.
doi:10.1371/journal.pbio.0050029.g001
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(A) VIP binding isotherm of EB1-EGFP to aEB1-antibody interaction fitted with a one site–binding model. A.U., arbitrary units.
(B) Interaction of EB1-EGFP (prey: EGFP protein added to the extract) with APCMTBD (bait: recombinant protein added to the extract that binds to the
anti-APC–coated beads) in metaphase (M, open bars) and interphase (I, filled bars). The three pairs of bars correspond to three independent
experiments carried out in different extracts. A.U., arbitrary units; exp, experiment.
(C) FRET binding isotherm of recombinant XMAP215-EGFP to recombinant EB1Cy3 in CSFXB buffer (left panel) and the VIP binding isotherm of
recombinant XMAP215 to EB1-EGFP in CSFXB buffer (right panel). Both isotherms are fitted with one site–binding models. A.U., arbitrary units.
(D) IP of XMAP215 or EB1 (left panel) and XMAP215/EB1-EGFP VIP (right panel) in interphase and metaphase extracts. Co-precipitation of EB1 or
XMAP215 in IP experiments was probed by SDS-PAGE/immunoblotting with the respective antibodies (immunoblot [IB] with XMAP215 antibody and
with EB1 antibody). In the VIP experiment, endogenous XMAP215 served as bait and EB1-EGFP as fluorescent prey. In the right panel, the four pairs of
bars correspond to four independent experiments performed in metaphase (M, open bars) and interphase (I, filled bars) extracts. A.U., arbitrary units;
exp, experiment.
(E) Left panel shows IP pull down of 2 lM GST and GST-C-EB1 using apolyclonal aGST antibody. Co-precipitation of XMAP215 was probed by SDS-PAGE/
immunoblotting with the XMAP215 antibody (IB: XMAP215). Immunoblot (IB) with monoclonal aGST antibody (m-GST) shows that GST and GST-C-EB1
were added to interphase and metaphase extracts accordingly. Right panel shows the VIP experiment of EB1-GST-C-EB1Cy5 and XMAP215-GST-C-
EB1Cy5 in metaphase (M, open bars) and interphase (I, filled bars) extracts. Error bars represent the s.e.m. of ,IVIP. derived from at least three different
microscopic fields. A.U., arbitrary units, exp, experiment.
doi:10.1371/journal.pbio.0050029.g002
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interactions ‘‘in extract’’ that have been reported to occur by
classical IPs. This, together with other controls involving
FRET techniques, validates the VIP method. However, VIP
has some limitations. The epitopes of some molecules may
not be accessible to the antibodies used. It is therefore
desirable to check interactions with several antibodies and to
include positive controls in the assay whenever possible. VIP
does not tell whether the interaction is direct or indirect, and
it requires puriﬁed recombinant proteins and speciﬁc anti-
bodies, as well as ﬂuorescently labeled proteins. However,
unlike FRET assays, VIP does not require that both
interaction partners be recombinant, ﬂuorescently labeled
proteins. Furthermore, multiple interaction pairs can be
visualized simultaneously in the same image. The use of VIP
can easily be extended to the study of spatial regulation of
interaction networks, since interaction signals are stored
together with bead coordinates. Most importantly, measure-
ments are made in situ, so that molecular interactions can be
monitored in extracts shifting between cell-cycle states.
Figure 3. Change in the MAP Interaction Network at Interphase/Metaphase Transition
(A) Pairwise interaction of MAPs in interphase and metaphase are represented as color-coded tables (upper panel). The color code corresponds to
,IVIP. of at least three different microscopic fields. Proteins in green are EGFP tagged, and those in blue are Cy5 labeled. Below each table is a
schematic representation of the network states in interphase and metaphase. Line thickness corresponds to interaction strength normalized to the
strongest signal detected in interphase or metaphase. In the lower panel, an interphase aster is shown on the left and a mitotic one on the right
(B) CDK1 activity induced a change in EB1-APCMTBD and EB1-XMAP215 interactions. EB1-EGFP fluorescence was measured simultaneously on beads
coated with anti-XMAP215 and anti-APCMTBD antibodies in the presence of APCMTBD, and added to metaphase, interphase, and interphase extracts
after addition of active, purified CDK1. Error bars represent the s.e.m. of ,Ivip. measured in six different microscopic fields. A.U., arbitrary units.
(C) XMAP215/EB1-EGFP interaction in metaphase (open bars) and XMAP215/XKCM1-EGFP and APCMTBD/EB1-EGFP interaction in interphase (filled bars)
before (control) and after incubation with 10 lM okadaic acid (OA). Error bars represent the s.e.m. of ,IVIP. derived from at least three different
microscopic fields.
doi:10.1371/journal.pbio.0050029.g003
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Protein Network and Microtubule DynamicsFigure 4. MT Stabilizing Activities of EB1 and XMAP215 in Interphase and Metaphase Xenopus Egg Extracts
(A) Average size of asters in response to depletion of XMAP215 (DXMAP215) from the extract and the addition of recombinant EB1 to the DXMAP215
extract. Error bars represent the S.D. (n . 30). Upper panel: immunoblot (IB) of MAPs after indicated treatments.
(B) Average size of asters in response to depletion of EB1 (DEB1) from the extract and the addition of recombinant XMAP215 to the DEB1 extract. Error
bars represent the S.D. (n . 30). Upper panel shows the immunoblot (IB) of MAPs after the indicated treatments.
(C) Still images of MT asters after the indicated treatments are shown in the upper panel. Table summarizing the dynamic parameters of MT growth in
response to EB1 depletion (DEB1) and add back of recombinant EB1 into DEB1 interphase extracts is shown in the lower panel.
doi:10.1371/journal.pbio.0050029.g004
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Protein Network and Microtubule DynamicsUsing this technique, we have revealed a systematic change
in the conﬁguration of MAPs interactions between interphase
and mitosis. Most strikingly, a major MT destabilizer, XKCM1,
was found to interact with EB1, XMAP215, APC, and CLIP170
in interphase, interactions that are all lost or considerably
reduced in the metaphase extract. This change in interactions
may be caused by still-unknown phosphorylation events. By
contrast, we found a robust interaction between XMAP215
and EB1 in metaphase that could not be detected in the
interphase cytoplasm. This is probably also due to phosphor-
ylation changes since this interaction cannot be revealed by
classical IP (Figure 2D), which suggests that the phosphor-
ylation state of these molecules is dynamic and lost quickly
when the extract is diluted. An interesting future challenge
will be to determine what kind of phosphorylation events are
required to induce the switch in the overall MAP interaction
pattern.
Because VIP does not allow the determination of whether
the interactions detected are direct, it is likely that the
network of protein interactions involved in the regulation of
MT dynamics is larger than the one we have revealed. In
effect, the action of the C-EB1 on MT dynamics in metaphase
(Figure 5A) may be the result, not only of an inhibition of the
XMAP215-EB1 interaction, (Figure 5A, inset), but also of a
more complex change in a series of interactions between
partners of the network.
We have provided experimental results in support of the
idea that there is a causal relationship between the two
different states of this small network of interactions and the
corresponding state of MT dynamics. In this context, it is
interesting that XMAP215 interacts with tubulin both in
interphase and mitosis. This suggests that in extracts, MT
growth occurs by incorporation of tubulin-XMAP215 com-
plexes. XMAP215 is supposed to stabilize tubulin oligomers
and may lead to the incorporation of short protoﬁlament
segments into MTs, which would explain its effect on the MT
growth rate [28]. In connection with this and in relation to
the regulation of MT dynamics between interphase and
mitosis, it is interesting to note that in interphase, XMAP215
interacts with XKCM1, which is surrounded by EB1, CLIP170,
and APC, whereas in mitosis, it does not interact with
XKCM1, but rather with EB1. If we assume that XMAP215 is
incorporated into MTs together with tubulin subunits, one
could imagine that these other molecules come along as well.
In interphase, XKCM1 catastrophe activity seems to be
buffered out through its interactions with the other MAPs.
It may be incorporated in the growing MT in an inactive
form, whereas in metaphase it may be free to act directly at
the tip of MTs or diffuse passively along the MT lattice toward
the plus end to induce catastrophes [29]. In mitosis, the
tubulin-XMAP215-EB1 complex seems important to deter-
mine the exact MT dynamics of the mitotic state because
removal of EB1 eliminates all MT growth. It is not surprising
that an overexpression of XMAP215 overcomes EB1 deple-
tion if we assume that the tubulin-XMAP215 complex is the
unit that is incorporated into forming MTs. Indeed, by
increasing the concentration of this complex, one increases
the concentration of subunits available for MT assembly,
thereby favoring it. Another interesting outcome of this study
concerns the function of APC and EB1. It has been suggested
on the basis of in vitro results that these two molecules
stabilize MTs when they interact [6]. Here we found that
under physiological conditions, they do not interact—at least
not in the cytoplasm. Moreover, EB1 is neither essential for
MT growth in interphase nor in mitosis, in which it seems to
have a regulatory role. APC is also not required for MT
growth either in mitosis or interphase. However, double
depletion of APC and EB1 does result in very short MTs in
interphase (Figure 6C and 6D). If one looks at the interactions
between EB1, XKCM1, and APC in interphase (Figure 3A),
this is entirely consistent with the idea that the catastrophe-
promoting activity of XKCM1 is inhibited by its interaction
with XMAP215, APC, and EB1. Indeed, when both EB1 and
APC are depleted, the steady-state concentration of free
XKCM1 probably increases, resulting in MT destabilization.
We actually demonstrated this by doing a triple depletion
experiment of APC, EB1, and XKCM1 from interphase
extracts that did not result in MT shortening. On the
Figure 5. C-EB1 Inhibits XMAP215-EB1 Interaction and Destabilizes MTs in Metaphase Xenopus Egg Extracts
(A) Effect of EB1 fragments on aster size (6S.D., n . 30) in undepleted and DEB1 metaphase extracts. VIP experiment of XMAP215/EB1-EGFP interaction
in metaphase extract in response to addition of buffer (control), N-terminal domain (N-EB1), linker domain (L-EB1), or C-terminal domain (C-EB1) of EB1
(inset). Error bars represent the s.e.m. of ,Ivip. measured in three different microscopic fields.
(B) Effect of C-EB1 on aster size in interphase (6 S.D., n . 30)
doi:10.1371/journal.pbio.0050029.g005
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Protein Network and Microtubule DynamicsFigure 6. The MT Destabilizing Activity of XKCM1 Is Inhibited by MAPs in Interphase Egg Extracts
(A) Still images and table summarizing the dynamic parameters of MT growth in response to XKCM1 depletion (DXKCM1) and add back of the
recombinant protein.
(B) Aster size after stepwise addition of recombinant XKCM1 into undepleted interphase and metaphase extracts. Error bars represent the S.D. (n . 30).
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Protein Network and Microtubule Dynamicscontrary, upon depletion of XKCM1 in the DAPC and DEB1
extract, MTs grew from rather short ones (;9 lm) to almost
control levels (;18 lm), demonstrating that XKCM1 was
responsible for MT destabilization in the DAPC and DEB1
extract. The observation that EB1 or APC single depletion
does not signiﬁcantly destabilize MTs in interphase does not
conﬂict with our model. It rather indicates that there is an
excess of ‘‘XKCM1 buffering capacity’’ present in interphase
extracts constituted by a variety of MAPs whose individual
functions are somewhat interchangeable as far as inactivation
of XKCM1 is concerned. This may explain how the inhibition
of XKCM1 activity in interphase can be maintained at a
constant level even if one speciﬁc MAP is removed. Thus, the
inhibitory effect of individual MAP depletion on XKCM1
activity only becomes obvious when the ‘‘total buffering
capacity’’ is overloaded (e.g., by adding exogenous XKCM1).
It seems that we are getting closer to an understanding of
how MT growth is regulated in interphase and mitosis: MT
assembly in vivo probably does not only involve tubulin
assembly into tubes. Rather, tube assembly may involve
oligomeric complexes of tubulin and other MAPs. It is
conceivable that XMAP215 has evolved as a major linker
and essential protein between tubulin and these other MAPs.
Regulation of MT assembly between interphase and meta-
phase then largely occurs through a regulation of the state of
dynamic interactions between XMAP215 and other MAPs in
solution. It remains to be determined how this is achieved by
CDK1: directly or indirectly. It is tempting to think that
CDK1 alters the balance between kinases and phosphatases
that modulate the dynamics of interactions between
XMAP215 and the other MAPs.
Materials and Methods
Antibodies. Antibodies directed against GST protein as well as
against Xenopus laevis full-length EB1, XKCM1 (1–264 amino acids),
CLIP170 H2, APCMTBD, and XMAP215 (1–560 amino acids) (Figure
S1A) were generated by immunizing rabbits with recombinant
proteins according to standard procedures. Polyclonal sera were
afﬁnity puriﬁed on recombinant proteins covalently linked to NHS-
activated Sepharose (Pharmacia, Uppsala, Sweden). Antibody direc-
ted against p150
glued was purchased from BD Transduction Labo-
ratories (Lexington, Kentucky, United States). Monoclonal mouse-
raised antibody directed against GST protein ([m-GST] GST 26H1)
was purchased from Cell Signalling Technology (Beverly, Massachu-
setts, United States).
Cloning of expression constructs. MAP cDNAs are from X. laevis
and, unless otherwise noted, comprise the complete cDNA sequence.
EB1-EGFP was generated by fusing the EGFP (Clontech, Palo Alto,
California, United States) cDNA sequence via a linking region
(encoding 10xGly) to the sequence of EB1. Both, the EB1 and
EGFP-EB1 cDNA sequences were subcloned into a pHAT2 vector for
bacterial expression. GST-EB1 fragments were generated by PCR
using the EB1 cDNA as a template and inserted into the pGEX 6P-1
expression vector (Pharmacia). The XMAP215 cDNA clone was a gift
from A. Popov (INSERM, Grenoble, France). For expression in SF9
cells, XKCM1 cDNA was generated by PCR and placed into
pFASTBac I (Invitrogen, Carlsbad, California, United States). EGFP-
XKCM1 was created by subcloning of the EGFP and XKCM1
sequences into the pFASTBac HTa vector (Invitrogen). The MT-
binding domain of APC (APCMTBD) was generated by PCR of APC as
a template and inserted into pGEX-6P-I (Pharmacia).
Protein expression, puriﬁcation, and ﬂuorescent labeling. X. laevis
EB1 and GST-EB1 fragments, GST-APCMTBD were expressed in
Escherichia coli (BL21) and puriﬁed on TALON beads (Clontech) and
glutathione Sepharose beads (Pharmacia), respectively, according to
the manufacturers’ instructions. XMAP215 and XKCM1 were ex-
pressed and puriﬁed as previously described [3,30]. His-EGFP-
XKCM1 was expressed in Sf9 cells using the BactoBac system
(Invitrogen) following the manufacturer’s instructions. The puriﬁca-
tion was done 48-h postinfection with 50 ml of SF9 cells (1310
6 cells/
ml) expressing X. laevis full-length EGFP-XKCM1 (Figure S1B), which
was harvested by centrifugation at 5003g for 10 min. Pellets were
washed with phosphate buffered saline (PBS) containing a protease
inhibitor cocktail (Roche Cat.No.11 873 580 001; Basel, Switzerland)
and ﬁnally resuspended in 10 ml of PBS þ protease inhibitors. Lysis
was achieved by three freeze/thaw rounds, and the crude lysate was
cleared by a 10-min centrifugation step at 12,0003g. The cleared
lysate was bound to 0.5 ml of pre-equilibrated TALON beads
(Clontech) and incubated at þ4 8C for 1.5 h .The resin was washed
three times with PBS þ10 mM imidazole, and the protein was eluted
in four steps with 0.5 ml of PBS þ 150 mM imidazole. The protein
concentration was determined, and the buffer was changed to BRB80
(80 mM PIPES [pH6.8], 1 mM MgCl2, and 1 mM EGTA) þ 10%
glycerol by dialysis.
Fluorescent labeling of proteins was performed using Cy5- and
Cy3-monofunctional reactive dye (Amersham Biosciences, Little
Chalfont, United Kingdom) according to the manufacturer’s instruc-
tions. Active CDK1 was puriﬁed from Xenopus egg extract as
previously described [16].
Extract preparation. X. laevis cytostatic-factor metaphase-arrested
extracts were prepared as described [13]. Interphase extracts were
prepared by adding 0.4-mg/ml CaCl2 to the metaphase extract and
incubated for 90 min at 20 8C. Aliquots of extracts were frozen in
liquid ethane, stored in liquid nitrogen, and quickly thawed just
before use.
MAP Immunodepletions, IP, and Western blots. Extracts were
immunodepleted of MAPs as described elsewhere [31] and directly
used for spindown of MT asters according to published procedures
[32]. For MT dynamics experiments, the extract was depleted prior to
freezing in liquid ethane. For evaluation of endogenous and
exogenous MAPs levels in the extract, 0.5 ll of the sample was loaded
onto either 6%–15% (for EB1, XMAP215, and XKCM1), or 4%–15%
(for APC) SDS-PAGE gradient gels and processed for Western
blotting. IPs were performed in the same way as immunodepletions
for appropriate MAPs. The obtained beads were washed four times
with PBSþ0.1% Triton X-100 and dissolved in the sample buffer, and
then the entire volume was loaded onto SDS-PAGE gradient gels and
processed for Western blotting.
MT aster size and dynamics. Images of asters were acquired using a
Zeiss Axiovert 135 microscope (Zeiss, Oberkochen, Germany)
equipped with a CoolSNAP camera (Roper Scientiﬁc, Trenton, New
Jersey, United States), a 633 Plan-apochromat NA 1.4 oil-immersion
objective lens, and a long-pass rhodamine ﬁlter (Chroma Technology
Corp, Rockingham, Vermont, United States). The shape of the asters
was classiﬁed into either radial or comet-like. For the former, an
integrated circular intensity proﬁle was generated, whereas for the
latter (majority in interphase), an intensity proﬁle along the major
axis of the comet was generated. We used a custom macro written
using MATLAB (MatWorks) to quantify the average length of MTs in
each aster on the basis of proﬁles representing the average pixel value
at radially increasing distances from the aster center. Aster size was
determined by the distance corresponding to the half-maximum of
the proﬁle amplitude [33]. At least 30 asters per condition were
analyzed.
Time-lapse recordings (2-s intervals) were obtained using a Zeiss
Axiovert 200 microscope equipped with a CoolSNAP camera (Roper
Scientiﬁc), a 1003 Plan-apochromat NA 1.4 oil-immersion objective
Inset shows the Western blot of extracts containing increasing amounts of recombinant XKCM1 (XKCM1rec ¼ amount of XKCM1 added in nM; and IB:
XKCM1 ¼ immunoblot with anti-XKCM1 antibody).
(C) Aster size after stepwise addition of recombinant XKCM1 into control (IgG) depleted (indigo line), XMAP215 depleted plus 40 nM XMAP215 (red line),
APC depleted (pink line), EB1 depleted (dark yellow line), and APC and EB1 depleted (cyan line) interphase extracts. Error bars represent the S.D. (n .
30).
(D) Western blot of extracts containing increasing amounts of recombinant XKCM1 (XKCM1rec ¼ amount of XKCM1 added in nM; and IB: XKCM1 ¼
immunoblot with anti-XKCM1 antibody) that were depleted of specified MAPs.
doi:10.1371/journal.pbio.0050029.g006
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Protein Network and Microtubule Dynamicslens, and a long-pass rhodamine ﬁlter (Chroma). After measuring MT
length in the ﬁlms, MT dynamics were analyzed using a custom-
written MATLAB macro to determine the growth rate (Vg), the
shrinkage rate (Vs), the catastrophe frequency (fcat), and the rescue
frequency (fres) from graphs in which length of MT versus time is
plotted. Minimum slope for MT growth or shrinkage was set to 0.05
lm/sec, and minimal growth or shrinkage length since last transition
was set to 0.5 lm. MT growth/shrinkage/pause tendency had to persist
for at least 6 s in addition to the above-mentioned criteria for a
transition event to be scored; otherwise a change in MT behavior
would be contributed to a tracking error.
VIP sample preparation and data acquisition. Magnetic protein-A
(Invitrogen) beads were incubated with saturating amounts of
polyclonal, afﬁnity-puriﬁed anti-MAP antibody (bait bead) or
Alexa405-labeled IgG (control) for 1.5 h at 4 8C. Different baits were
encoded by tracing the fraction of speciﬁc MAP antibody with
different amounts of Alexa405-IgG. The extract was pretreated with
40 lM nocodazole for 20 min on ice to completely inhibit MT
polymerization. The nocodazole-treated extract was incubated with
ﬂuorescent prey protein, concentrated hemoglobin solution, and a
mix of bait and control beads for 15 min at 20 8C. Prey proteins were
added at near endogenous concentrations (e.g., XKCM1-EGFP and
EB1-EGFP at 500 nM). Each lane of a plastic perfusion chamber (Ibidi,
Munich, Germany) was loaded with 20–40 ll of the extract/bead
suspension. Images were acquired with a SP2 AOBS laser-scanning
microscope (Leica, Wetzlar, Germany) using a HCX 633 Plan-
apochromat NA 1.4 oil-immersion objective lens. Alexa405 (detec-
tion: 410–470 nm), EGFP (detection: 500–540 nm), and Cy5 emission
(detection: 640–730 nm) were acquired by sequential line scanning
using the 405-nm, 488-nm, and 633-nm laser lines for excitation. For
each sample, at least three different microscopic ﬁelds were acquired
for calculation of the standard error of the mean (s.e.m.) All routines
for automated VIP-image-processing were written in MATLAB 6.1
(ﬂow chart of algorithm: Figure 1B).
FRET assay of XMAP215-EB1 interaction. EB1Cy3 (FRET acceptor)
was titrated into a 500 nM solution of XMAP215-EGFP (FRET donor)
in CSFXB buffer (0.1 M KCl, 2 mM MgCl2, 0.1 mM CaCl2, and 5 mM
EGTA) at 20 8C. Donor emission was measured as a function of
EB1Cy3 concentration using a spectroﬂuorometer (Photon Technol-
ogy, Lawrenceville, New Jersey, United States) and corrected for
dilution. From the quenched donor emission, EFRET was calculated as
EFRET(A)¼(IA0 IA)/IA0 where IA is the EGFP emission in the presence
of acceptor and IA0 is the EGFP emission without acceptor. The
binding isotherm (A ! EFRET) was ﬁtted with a one site–binding
model to obtain the Kd of the interaction.
Supplementary Information
Figure S1. Constructs and Recombinant Proteins Used
(A) List of (labeled) recombinant proteins/protein fragments used
(left panel) and list of afﬁnity puriﬁed antibodies used (right panel).
(B) Baculovirus expression and puriﬁcation of XKCM1-EGFP.
Coomassie blue–stained gel of crude Sf9 cells lysate, cleared Sf9 cells
lysate, ﬂow through, and eluted XKCM1-EGFP.
Found at doi:10.1371/journal.pbio.0050029.sg001 (1.5 MB PDF).
Figure S2. Combined Effects of MAPs Depletion of Aster Size
(A) Impact of XMAP215 and XKCM1 depletion (DXMAP215/
DXKCM1) on aster size. Upper panel: immunoblot (IB) of MAPs
after indicated treatment.
(B) Impact of APC and EB1 depletion (DAPC/DEB1) on aster size.
Upper panel: immunoblot (IB) of MAPs after indicated treatment.
(C) Impact of p150
glued depletion on aster size in metaphase and
interphase extracts.
(D) Impact of APC and EB1 depletion (DAPC&DEB1) as well as of
APC and EB1 and XKCM1 depletion (DAPC&DEB1&DXKCM1) on
aster size in interphase extract. Upper panel: immunoblot (IB) of
MAPs after indicated treatment. Error bars represent the standard
deviation (S.D.; n . 30).
Found at doi:10.1371/journal.pbio.0050029.sg002 (3.4 MB PDF).
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